Intermittent fasting brings no benefit beyond equivalent calorie restriction
Randomized trials comparing intermittent fasting with continuous calorie restriction show no superiority for weight loss. Meta-analyses conclude on equivalence for weight, waist circumference and cardiometabolic risk. The most studied protocol, the 16-hour window, has been compared with an equivalent reduction in intake. Opening a fasting window creates no metabolic advantage of its own: it mainly makes a lower intake easier.
Methodological difficulty explains part of the murkiness of the results. Many trials last less than six months, too short to observe a divergence in weight. Adherence deteriorates quickly with strict protocols. The net result depends on diet quality more than on the rhythm of meals.
The framework distinguishes established, probable and hypothetical. For weight, the effect is consistent but modest and not specific. For human longevity, the demonstration does not exist. The most flattering data come from short protocols in selected populations.
The 14 to 16 hour eating window remains the best tolerated modality
Not all variants of intermittent fasting are equivalent. The eating window skips one or two meals, alternate-day fasting requires eating nothing every other day. The first concentrates most of the trials and lends itself to follow-up over several months. 24-hour fasts cause more side effects and lower adherence.
The main value of the eating window lies less in a biological effect than in fewer food decisions. Eating twice a day simplifies planning and often lowers spontaneous intake. The risk is symmetrical: meals inside the window become larger, saltier, sweeter. Diet quality matters more than the number of fasting hours.
The tolerance profile varies, and that variability must be respected. Headaches at the start, fatigue at the end of the window and cravings are the most frequent signs of adaptation. Someone prone to glycemic discomfort or food anxiety has no reason to impose a demanding protocol. Insulin-resistant profiles, by contrast, draw the clearest glycemic benefits. Tolerance also depends on the pace of life and on sleep quality.

Fasting glucose moves little and inconsistently
The most discussed parameter with the person being supported is fasting glucose. Trial results are heterogeneous and the effects modest. Some studies report a fall of a few thousandths after three to twelve months, others no difference from continuous calorie restriction. This variability is explained by the populations chosen and the protocols, from 12 to 20 hours. The eating window can help some people, without replacing treatment.
The other metabolic markers do not all follow the same trajectory. Waist circumference moves like weight, with no advantage specific to fasting. Triglycerides fall in several trials, with an order of magnitude close to that of calorie reduction alone. None of these results justifies changing the management of diabetes.
Intermittent fasting brings no demonstrated benefit for muscle protein status. Periods of prolonged fasting increase protein oxidation and weaken the muscle reserve of older adults. In an undernourished person, the eating window can worsen muscle loss. Lean mass is protected by strength work and protein, not by the rhythm of meals.
| Outcome assessed | Result compared with continuous calorie restriction | Level of evidence |
|---|---|---|
| Body weight | Difference below 1 kg, not significant | Established |
| Waist circumference | Reduction comparable to continuous restriction | Established |
| Fasting glucose | Modest fall, absent in several trials | Probable |
| HOMA-IR index | Inconsistent improvement depending on population | Probable |
| Muscle strength and mass | No specific benefit demonstrated | Probable |
| Human lifespan | No controlled trial available | Not demonstrated |
| Adherence at six months | Marked decline with strict protocols | Established |
Summary of randomized trial results on intermittent fasting

An intermittent fasting meta-analysis must be read through its excluded populations
Reading an intermittent fasting meta-analysis starts with the populations it excludes. Most trials leave out pregnant women, children and people with major excess weight. Patients on insulin are almost systematically excluded. A benefit observed in a selected population does not transfer to the person in front of you.
Trial duration limits the reach of the conclusions, many stopping at twelve weeks. Several publications compare fasting with a group that received no equivalent nutritional advice, which overstates the gap. Primary criteria are often surrogate markers. Reading the bounds of the confidence interval is more informative than the central value.
Distinguishing observed benefit from expected benefit avoids many disappointments. Someone expecting rapid weight reduction generally gets an average result. Someone expecting a simpler food organization often gets a lasting benefit. Assessment criteria are set in advance, on concrete parameters.
24-hour fasts and long protocols fall under medical supervision
The risk profile depends on the protocol, not on the word fasting alone. A 14-hour window carries no particular risk for most adults. Fasts of 24 to 48 hours fall under medical supervision. People treated with insulin require closer monitoring, because the hypoglycemic risk is real. Undernourished older adults, pregnant women and adolescents are not candidates for unsupervised use. A history of eating disorder adds a risk of decompensation.
The first side effects appear in the first three days: morning headaches, fatigue at the end of the window, cravings and reflux. Dehydration and insufficient electrolyte intake explain part of this discomfort. Resuming food gradually after a long fast reduces the risk of refeeding complications. Monitoring glucose, hydration and strength makes it possible to stop the protocol without harm.
Tracking adherence requires a simple interview. Adherence under three months should lead to easing the protocol rather than tightening the requirement. Gains obtained before stopping are usually kept after food intake resumes. The weight trajectory then depends on the return of previous habits.
The choice of protocol and its assessment criteria are decided with the person
The protocol is chosen according to the person, not according to the trend of the moment. The starting point is to document meal rhythm, work schedules and constraints. The 14 to 16 hour window is the most frequently retained entry point. Spreading 25 to 30 g of protein per meal secures muscle reserves.
Assessment criteria are set before the protocol begins, on concrete parameters. Waist circumference, weight, fasting glucose, hunger, sleep and energy form a simple set of indicators. An assessment at three months avoids pursuing a strategy with no measurable effect. Stopping the protocol is then the most rational decision. It should not be experienced as a failure.
The professional's stance remains that of a documented reading rather than a doctrine. The intermittent fasting meta-analysis places the expected effect at the level of calorie restriction, not beyond it. The eating window can be offered as one adherence tool among others, without replacing treatment or strength work. This position makes the discussion fruitful with the person being supported.

Sources
- 1.Cioffi I, et al. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. J Transl Med. 2018.
- 2.Welton S, et al. Intermittent fasting and weight loss: systematic review. Can Fam Physician. 2020.
- 3.Wei M, et al. Fasting-mimicking diet and markers and risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med. 2017.
- 4.Semnani-Azad Z, et al. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis. BMJ. 2025.
- 5.Ezpeleta M, et al. Time-restricted eating: watching the clock to treat obesity. Cell Metab. 2024.
- 6.Varady KA, et al. Cardiometabolic benefits of intermittent fasting. Annu Rev Nutr. 2021.
- 7.McHill AW, et al. Eating around the clock: circadian rhythms of eating and metabolism. Annu Rev Nutr. 2024.
Reading studies is one thing, turning them into a plan is another
The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.
11 modules, €2,200. Enrol
Continue reading
Benjamin Sant
Co-founder of the School of Longevity
Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.
This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.
